Scientific and Ethics Advisory Committee (SEAC)

Prof. Dr. med. Isabelle Bekeredjian-Ding took over as head of the Department of Microbiology at the Paul Ehrlich Institute in 2015. The focus of her research and clinical experience is infectious diseases. Her extensive regulatory expertise includes microbiological safety of biomedical drugs, infectious disease product evaluation, and preclinical and clinical vaccine development.

She has served as a member of the Pandemic Task Force and the Vaccines Working Party of the European Medicines Agency (EMA) and as Chair of the Scientific Committee of the Innovative Medicines Initiative 2 (IMI2). Thus, Prof. Dr. Bekeredjian-Ding has several years of experience in one of the world's most important public-private partnerships in healthcare.

​ORCID ID: 0000-0001-6646-5888, Scopus ID: 14008282400

Dr Jocelyn Raude is a full professor of health psychology at the Department of Social and Behavioral Sciences of the EHESP School of Public Health in Rennes (France) and Research associate at the “Emerging Viruses” Unit (UMR 190 AMU-IRD-INSERM) in Marseille (France). His research interests focus on interactions between epidemiological contexts and human behaviors, as well as the social and psychological mechanisms through which individuals and communities adapt their behavioral patterns and lifestyles in response to emerging health threats – particularly in the domain of mosquito-borne and respiratory infectious diseases

Martina is a microbiologist with extensive experience in vaccines development. She obtained a PhD from the University of Tübingen, Germany, followed by post-doctoral research at the University of British Columbia, Canada. Martina held positions with increasing responsibility in the vaccines division of the French multinational pharmaceutical company Sanofi where she worked on pre-clinical and early clinical stage vaccines against multiple bacterial pathogens including Mycobacterium tuberculosis, Streptococcus pneumoniae, and Bordetella pertussis. Her work was recognized in patent filings and publications in peer reviewed journals. Martina filled leadership roles in the PERISCOPE and INNO4VAC consortia that were supported through the EU Innovative Medicines Initiative. 

Martina joined the Coalition for Epidemic Preparedness Innovations in April 2022 and focuses now on RNA vaccine technology, viral pathogens with outbreak potential and support of CEPI’s 100 Day Mission. 

In 2023 Dr Pozzi retired from the position of Full Professor of Micobiology at the University of Siena and was awarded the honorary title of SENIOR PROFESSOR at the same 
University. 
EDUCATION: Maturità Classica (Scuole Pie Fiorentine, 1974), Laurea in Medicina (M.D.), (University of Siena Medical School, 1980), Postgraduate Specialization School in Medical Microbiology (University of Genoa, 1985).
ACADEMIC POSITIONS: Full Professor of Microbiology at the Universities of Siena (1997-2022) and Cagliari (1994-1997), Assistant Professor at the Universities of Padova (1994) and Verona (1987-1994), Visiting Professor at The Rockefeller University(1987), and Research Associate at Duke University (1982-1984).
RESEARCH INTERESTS include Bacterial Genetics and Genomics, Molecular Pathogenesis, Antimicrobial Drug Resistance, Recombinant Vaccine Vectors, Mucosal Vaccines, and Probiotics and the Human Microbiome.
PUBLICATIONS: Total number of scientific articles: 199 (Scopus). Total citations:7,056 (Scopus). H index: 48 (Scopus). ORCID: 0000-0002-9557-4714. Scopus 55547857400.